Economic Evaluation of Tympanostomy Tube Placement.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 41578617.
- Also identified by DOI 10.1002/lary.70391.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study is to compare the economics of in-office tympanostomy tube placement using single use devices versus standard placement in the operating room (OR). A retrospective chart review was completed for all pediatric patients who underwent in-office tympanostomy tube placement (CPT 69433) along with insurance and date matched patients with placement in the OR (CPT 69436) between 12/1/21-3/1/24. Financial data were compared among the public vs. private insurance cohorts using the Wilcoxon rank-sum test with a two-sided significance level of 5%. One hundred and thirty-six in-office patients were identified, 102 private versus 34 public, and compared with 136 insurance and date matched OR patients. The average total payment for both privately insured patients, $647.14 in-office versus $6873.45 in the OR, and publicly insured patients, $312.74 in-office versus $2656.34 in the OR, was statistically significant. The average insurance payment for both privately insured patients, $301.58 in-office versus $5445.73 in the OR, and publicly insured patients, $310.63 in-office versus $2258.65 in the OR, was statistically significant. For the patient payment, public insurance usually has 0 copay and is therefore excluded. The patient payment of the private insurance cohort, $308.30 in-office versus $670.61 in the OR, was not found to be statistically significant. As expected, this study demonstrates significant reductions in overall cost with in-office tympanostomy tube placement even with the added cost of single-use devices compared to the standard placement in the OR, particularly for insurance companies, suggesting the potential benefit of providing reimbursement for these devices. N/A.